GlassScriptPhysician profile
Jaime B Cannon
NPI 1073894168
$11,783.80
in general payments reported to CMS, 2019-2025
41 companies · $2,237 in 2025
The $2,237 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,655 · 2022: $2,895 · 2023: $2,630 · 2024: $2,367 · 2025: $2,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,233.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,279.28 | 2021-2025 | Airsupra, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $1,860.38 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Grifols USA, LLC | $815.29 | 2021-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $665.35 | 2021-2025 | Acthar, Terlivaz |
| Takeda Pharmaceuticals U.S.A., INC. | $653.61 | 2021-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $631.69 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Harmony Biosciences LLC | $545.64 | 2021-2024 | Wakix |
| Regeneron Healthcare Solutions, INC. | $543.43 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $407.26 | 2021-2025 | Tyvaso, Tyvaso |
| Csl Behring | $400.16 | 2021-2025 | Hizentra |
| Amgen INC. | $360.02 | 2022-2025 | Tezspire |
| Mylan Specialty L.P. | $328.03 | 2021-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $293.48 | 2022-2025 | Zerbaxa, Dificid, Recarbrio |
| Genzyme Corporation | $266.23 | 2024-2025 | |
| Philips North America LLC | $175.65 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $151.13 | 2023-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| La Jolla Pharmaceutical Company | $137.77 | 2021-2024 | Giapreza |
| Inogen, INC. | $129.13 | 2022-2024 | Inogen At Home Stationary Concentrator |
| Vifor Pharma, INC. | $122.79 | 2024-2025 | Zemaira |
| Astellas Pharma US INC | $121.80 | 2021-2024 | Cresemba |
| Ani Pharmaceuticals, INC. | $119.50 | 2022-2023 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $109.83 | 2025 | Yupelri |
| Gilead Sciences, INC. | $106.03 | 2021-2023 | |
| Intuitive Surgical, INC. | $86.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $44.67 | 2021-2022 | |
| Verona Pharma, INC. | $44.09 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $41.90 | 2021-2022 | |
| Pfizer INC. | $40.78 | 2024 | |
| Lilly USA, LLC | $39.24 | 2025 | Zepbound |
| Axsome Therapeutics, INC. | $38.74 | 2025 | Sunosi |
| Baxter Healthcare | $37.89 | 2022-2024 | Hillrom - Monarch Airway Clearance System |
| Teva Pharmaceuticals USA, INC. | $28.30 | 2021-2023 | Airduo Digihaler |
| Inspire Medical Systems, INC. | $24.22 | 2025 | Inspire |
| Insmed, INC. | $23.67 | 2024 | Arikayce |
| Getinge USA Sales, LLC | $19.65 | 2024 | Cardiosave Hybrid, Type B Plug |
| Vapotherm INC | $17.93 | 2022 | |
| Abbvie INC. | $17.26 | 2023 | |
| Melinta Therapeutics, LLC | $16.73 | 2023 | Vabomere, Rezzayo |
| Genentech USA, INC. | $16.38 | 2024 | Xolair |
| Bayer Healthcare Pharmaceuticals INC. | $12.88 | 2021 | |
| Breas Medical, INC. | $9.99 | 2025 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Cannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.